ClinicalTrials.Veeva

Menu

Prospective Assessment Project of AirwaY Management-related Incidents in Adult Anaesthesia Care PAPAYA III (PAPAYA-III)

I

Insel Gruppe AG, University Hospital Bern

Status

Not yet enrolling

Conditions

Adverse Events
Airway Complication of Anesthesia

Study type

Observational

Funder types

Other

Identifiers

NCT06117176
PAPAYA III
2023-01752 (Registry Identifier)

Details and patient eligibility

About

The overall objective of the study is to evaluate and analyze major and minor incidents during airway management in adults under anaesthesia care at all study sites. The patient characteristics, type of airway management is recorded and if airway management-related incidents occur, they are analyzed in more detail to improve patient safety in the future.

Full description

It is a prospective observational cross-sectional European multi-centre study collecting health-related patient data on anaesthetic airway management over three months. This detects the incidence and nature of local airway management problems and assesses how they are solved. This will enable the investigators to identify generalisable interventions and recommendations to further improve patients' airway management to improve patient safety. During the observational period, the anaesthesia staff in charge will fill out a screening questionnaire for airway management for every patient undergoing anaesthesia care with airway management. The investigators will extract the characteristics from the local anaesthesia record system for all patients. If no event arises, there are no further requirements. If an event occurs, the anaesthesia provider will fill out an additional form asking for more details on what happened.

Enrollment

40,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All adult patients requiring airway management under anaesthesia care for elective, semi-elective, urgent or emergency diagnostic procedures or interventions. Airway management includes awake and asleep tracheal intubation, insertion of supraglottic airway devices, and face mask ventilation.
  • Patients older than 18 years of age
  • Informed consent given or general consent in place, according to local ethics committee requirements.

Exclusion criteria

  • Refusal to give consent or withdrawal of consent.
  • Patients <18 years.

Trial contacts and locations

4

Loading...

Central trial contact

Alexander Fuchs, MD; Thomas Riva, MD,PD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems